:: DCL Pathologists ::

DCL Pathologists

Michael Glant, M.D.
Board Certified in Anatomic/Clinical Pathology; Subspecialty: Cytopathology
A founder of DCL, Dr. Glant is a nationally known cytopathologist with pioneering and ongoing work in fine needle biopsy (especially head/neck and lymph nodes).Dr.
Glant also has strong experience in gynecologic pathology (cytology and surgical pathology) with special experience in endometrium (changes with HRT, SERMs, and SPRMs in FDA clinical trials), breast pathology (with related prognostic/diagnostic markers) and pathology informatics. Dr. Glant is DCL’s Chief Medical Officer.

Carol Eisenhut, M.D., M.B.A.
Board Certified in Anatomic/Clinical Pathology; Subspecialty: Cytopathology
Dr. Eisenhut has been a DCL pathologist for 17 years. Her expertise includes fine needle biopsy, breast, endometrial, cervical, prostate, urinary bladder and gyn cytology. She manages the pathology group and serves as the Vice President of Medical Operations and the Indianapolis Laboratory Director. Dr. Eisenhut’s ongoing practice also includes FDA trials for gyn pathology and breast. She is DCL’s primary molecular pathology and microbiology laboratorian.

Sally Slowman, M.D., F.A.C.P.
Board Certified in Anatomic/Clinical Pathology; Subspecialty: Cytopathology
Dr. Slowman has been a DCL pathologist for 12 years. Her expertise includes fine needle biopsy, breast, endometrial, cervical, prostate, urinary bladder and gyn cytology. Her ongoing practice also includes FDA trials for gyn pathology and breast. Dr. Slowman has a special interest in seeing patients for fine needle biopsy. She is boarded in internal medicine and rheumatology.

D. Ian Smith, M.D., Ph.D.
Board Certified in Anatomic/Clinical Pathology; Subspecialty: Cytopathology
A DCL pathologist for 7 years, Dr. Smith’s expertise includes fine needle aspiration, surgical pathology of breast, endometrial, cervical and prostate disease, and gynecologic cytology. His ongoing practice also includes research trials for gynecologic and breast pathology. Dr. Smith has special interest in the procurement and interpretation of fine needle aspirations and is DCL’s in-house expert in immunohistochemistry.

Jennie Kho-Duffin, M.D.
Board Certified in Anatomic/Clinical Pathology; Subspecialty: Cytopathology
A DCL pathologist for 8 years, Dr. Kho-Duffin’s expertise includes fine needle biopsy, gynecologic and nongynecologic cytology, skin, breast, endometrial, cervical, prostate, urinary bladder surgical pathology. Her ongoing practice also includes FDA trials for gynecologic, gastrointestinal, skin and pleural pathology. She is DCL’s primary clinical pathology laboratorian.

Cynthia Benedict, M.D.
Board Certified in Anatomic/Clinical Pathology; Subspecialty: Cytopathology
Dr. Benedict has been a DCL pathologist for 6 years. Her expertise in cytopathology includes fine needle biopsy, urinary cytology and gynecologic cytology. Dr. Benedict’s expertise in surgical pathology includes cervical, endometrial, prostate and breast pathology. She also serves as DCL’s Fine Needle Biopsy Clinic leader and oversees aspects of its operation. Her ongoing practice also includes FDA trials for gyn pathology, gastrointestinal pathology and other cytology applications.

Charles Ndah, M.D.
Board Certified in Anatomic/Clinical Pathology; Subspecialty: Surgical Pathology
A DCL pathologist for 5 years, Dr. Ndah is our general surgical pathology expert in Indianapolis. He is also DCL’s primary genitourinary pathologist and lead for GI Pharmaceutical studies and has great interest in breast pathology/immunohistochemistry staining for prognostics/diagnostics.

Christopher Murphy, M.D.
Board Certified in Anatomic/Clinical Pathology; Subspecialty: Pediatric Pathology
A DCL pathologist for 6 years, Dr. Murphy is our primary hospital pathologist. He has developed his Gyn cytology expertise outside of fellowship training under the guidance of the Indianapolis staff and is proficient in all areas of gyn pathology, including paps, as well as GU and GI pathology. Dr. Murphy is also lab director of DCL’s St. Louis Region Laboratory.